NCT00232271View on ClinicalTrials.gov

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

PHASE4TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions
Deep Vein Thrombosis
Interventions
DRUG

Clexane

Trial Locations (1)

3050

Royal Melbourne hospital, Melbourne

Sponsors

Lead Sponsor

Melbourne Health

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

collaborator

National Heart Foundation, Australia

OTHER

lead

Melbourne Health

OTHER